ClinicalTrials.gov

History of Changes for Study: NCT04459286
The Nitazoxanide Plus Atazanavir for COVID-19 Study (NACOVID)
Latest version (submitted February 14, 2022) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 July 3, 2020 None (earliest Version on record)
2 August 31, 2020 Study Status, Contacts/Locations, Sponsor/Collaborators, Study Description and Oversight
3 October 11, 2020 Recruitment Status, Study Status, Contacts/Locations, Eligibility, Sponsor/Collaborators and Study Identification
4 February 1, 2021 Study Status and Contacts/Locations
5 October 29, 2021 Recruitment Status, Study Status, Contacts/Locations and Study Design
6 February 14, 2022 Recruitment Status and Study Status
Comparison Format:

U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services